Detalhe da pesquisa
1.
mRNA-based therapeutic strategies for cancer treatment.
Mol Ther
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702886
2.
RNA deadenylation complexes in development and diseases.
Biochem Cell Biol
; 101(2): 131-147, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645883
3.
Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.
Proc Natl Acad Sci U S A
; 114(23): 6016-6021, 2017 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533407
4.
Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis.
Nat Commun
; 15(1): 2340, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491013
5.
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.
Nat Chem Biol
; 7(11): 818-26, 2011 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21946277
6.
RNA modifications in hematological malignancies.
Int J Hematol
; 117(6): 807-820, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929506
7.
miR-148a-3p and DDX6 functional link promotes survival of myeloid leukemia cells.
Blood Adv
; 7(15): 3846-3861, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322827
8.
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.
Cell Rep Med
; 4(7): 101110, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467717
9.
RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells.
Nat Commun
; 14(1): 2290, 2023 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085479
10.
m6A RNA modifications: Key regulators of normal and malignant hematopoiesis.
Exp Hematol
; 111: 25-31, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487293
11.
Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.
Nat Cancer
; 2: 741-757, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458856
12.
Introductions to the Community: Early-Career Researchers in the Time of COVID-19.
Cell Stem Cell
; 27(6): 853-855, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275897
13.
HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells.
Nat Commun
; 11(1): 2026, 2020 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32332729
14.
The Biology of m6A RNA Methylation in Normal and Malignant Hematopoiesis.
Cancer Discov
; 9(1): 25-33, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30578356
15.
m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment.
Cell Rep
; 28(7): 1703-1716.e6, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412241
16.
Targeting the Residual Leukemia Cells after Chemotherapy.
Cancer Cell
; 34(3): 353-355, 2018 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30205040
17.
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.
Nat Med
; 23(11): 1369-1376, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28920958
18.
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
Nat Genet
; 49(6): 866-875, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436985
19.
The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells.
Stem Cell Reports
; 4(4): 658-69, 2015 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25754204
20.
Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential.
Int J Hematol
; 97(2): 198-209, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23288492